In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity ...

Adding darolutamide (Nubeqa) to androgen deprivation therapy (ADT) and radiation therapy significantly improved metastasis-free survival in patients with very high-risk prostate cancer, according to ...

A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take ...

South Korean biotech firm GI Innovation has administered the first dose in a global clinical trial combining its experimental ...

The new ASTRO guideline is based on a systematic review of evidence and expert opinion and includes recommendations for MHF, ...

Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...

Johnson & Johnson (J&J) said that an early-stage trial of JNJ-6143 (previously HLD-0915) found that the novel oral Regulated ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

On Thursday, O.J. Simpson, 76, lost his battle with cancer. Although the former football star became infamous for the murder trial he faced in the 1990s, in recent years, he had been photographed ...

In a retrospective study, high AI-derived whole-body tumor volume on PSMA PET-CT was associated with a 3.20-fold higher risk of death in prostate cancer.

Recent study links blood proteins to aggressive prostate cancer, identifying potential biomarkers for early risk prediction ...

Rodger Allen has been training in sand dunes to prepare for his desert challenge.